Clinical Pharmacokinetics and Pharmacodynamics of Dalcetrapib Donald M. BlackDarren BentleyTherese Heinonen Review Article Open access 05 May 2018 Pages: 1359 - 1367
Drug–Drug Interaction Profile of the Fixed-Dose Combination Tablet Regimen Ledipasvir/Sofosbuvir Polina GermanAnita MathiasBrian P. Kearney Review Article 11 April 2018 Pages: 1369 - 1383
Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics Ranjeet Prasad DashR. Jayachandra BabuNuggehally R. Srinivas Review Article 23 April 2018 Pages: 1385 - 1398
Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing Regimens Thomas TängdénPier Giorgio CojuttiFederico Pea Original Research Article 15 March 2018 Pages: 1399 - 1405
Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Hepatitis C Virus-Infected Cirrhotic and Non-cirrhotic Patients: Analyses Across Nine Phase III Studies Sathej GopalakrishnanSven MensingJiuhong Zha Original Research Article 07 March 2018 Pages: 1407 - 1419
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women Stein SchalkwijkRob ter HeineDavid M. Burger Original Research Article Open access 08 March 2018 Pages: 1421 - 1433
Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients Pieter J. ColinStijn JonckheereMichel M. R. F. Struys Original Research Article Open access 06 March 2018 Pages: 1435 - 1447
Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment Erik MogalianDiana M. BrainardAnita Mathias Original Research Article 08 March 2018 Pages: 1449 - 1457
A Limited Sampling Strategy to Estimate Exposure of Everolimus in Whole Blood and Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Using Population Pharmacokinetic Modeling and Bayesian Estimators Ida RobertsenJean DebordJean-Baptiste Woillard Original Research Article 20 March 2018 Pages: 1459 - 1469
Comment on “Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials” Joseph F. StandingBrian J. AndersonAmin Rostami-Hodjegan Letter to the Editor 20 July 2018 Pages: 1471 - 1472
Authors’ Reply to Standing et al.: “Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials” Sven C. van DijkmanNico C. B. de JagerOscar Della Pasqua Letter to the Editor 20 July 2018 Pages: 1473 - 1475